Christof Specker

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

Lorenzo Cavagna, Ernesto Trallero‐Araguás, Federica Meloni et al. · Journal of Clinical Medicine · 2019 · 214 citations · Full text

Life Sciences, Immunology, Internal Medicine +15

High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus

Andreas Perniok, F Wedekind, Martin Herrmann et al. · Lupus · 1998 · 213 citations

Life Sciences, Immunology, Pathology +13

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

Hans‐Peter Tony, Gerd R Burmester, Hendrik Schulze‐Koops et al. · Arthritis Research & Therapy · 2011 · 208 citations · Full text

Life Sciences, Dermatology, Immunology +16

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome

Lorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè et al. · Medicine · 2015 · 181 citations · Full text

Life Sciences, Immunology, Internal Medicine +17